
Susanne Hille
Articles
-
Sep 27, 2024 |
nature.com | Yuqin Wu |Susanne Hille |Jared Johnson |Cheng Huang |Mohammad Rahbari |Suchira Gallage | +7 more
AbstractThe peptide hormone glucagon is a fundamental metabolic regulator that is also being considered as a pharmacotherapeutic option for obesity and type 2 diabetes. Despite this, we know very little regarding how glucagon exerts its pleiotropic metabolic actions. Given that the liver is a chief site of action, we performed in situ time-resolved liver phosphoproteomics to reveal glucagon signaling nodes.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →